Factor VII activating protease (FSAP) inhibits growth factor‐mediated cell proliferation and migration of vascular smooth muscle cells.
Authors:
Open Access
- 20 February 2004
- journal article
- fj express-summaries
- Published by Wiley in The FASEB Journal
- Vol. 18 (6) , 728-730
Abstract
The factor VII activating protease (FSAP) is a serine‐protease present in human plasma that serves to activate single‐chain plasminogen activators, as well as coagulation factor VII. FSAP was localized within atherosclerotic lesions, and a genetic polymorphism in FSAP is associated with carotid stenosis. Hence, this study was conducted to gain broader insights into the cellular effects of FSAP on vascular smooth muscle cells (VSMC). DNA synthesis and cell proliferation assays revealed an inhibitory action of FSAP on platelet‐derived growth factor BB (PDGF‐BB)‐mediated proliferation of VSMC. FSAP also inhibited PDGF‐BB‐induced migration of VSMC. These cellular effects of FSAP could be neutralized by an anti‐FSAP mAb as well as by protease inhibitors such as aprotinin or a chloromethylketone inhibitor. Moreover, unfractionated heparin promoted the antiproliferative effect of FSAP on VSMC and was essential for the inhibition of VSMC migration. FSAP inhibited PDGF‐BB binding to human VSMC and concomitantly blocked PDGF‐BB‐dependent phosphorylation of mitogen activated protein kinase p42/p44 and tyrosine phosphorylation of other proteins. These results unravel a new function of FSAP as an inhibitor of the proatherogenic phenotype of vascular smooth muscle.Keywords
This publication has 27 references indexed in Scilit:
- Marburg I Polymorphism of Factor VII–Activating ProteaseCirculation, 2003
- The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP)Blood Coagulation & Fibrinolysis, 2002
- Factor VII Activating Protease (FSAP): A Novel Protease in HemostasisBiological Chemistry, 2002
- Factor VII and single‐chain plasminogen activator‐activating proteaseEuropean Journal of Biochemistry, 2001
- ldentification of the Substrates for Plasma Hyaluronan Binding Protein.Biological and Pharmaceutical Bulletin, 2001
- Activation of proPHBSP, the Zymogen of a Plasma Hyaluronan Binding Serine Protease, by an Intermolecular Autocatalytic MechanismBiological Chemistry, 2000
- Factor Xa Acts as a PDGF-Independent Mitogen in Human Vascular Smooth Muscle CellsThrombosis and Haemostasis, 2000
- Purification and Characterization of a Novel Hyaluronan-Binding Protein (PHBP) from Human Plasma: It Has Three EGF, a Kringle and a Serine Protease Domain, Similar to Hepatocyte Growth Factor ActivatorThe Journal of Biochemistry, 1996
- Induction of vascular smooth muscle cell growth by selective activation of the thrombin receptor Effect of heparinFEBS Letters, 1992
- Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells.Proceedings of the National Academy of Sciences of the United States of America, 1992